Sertraline and Phenprocoumon: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Sertraline
No brand names on recordPhenprocoumon
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
You've been prescribed sertraline (an antidepressant) along with phenprocoumon (a blood thinner). Both can affect your body's ability to form clots, so taking them together can raise your chance of bleeding.
Sertraline changes how tiny blood cells called platelets work, and phenprocoumon already slows clotting. Put together, you may notice things like nosebleeds, easy bruising, or bleeding that takes longer to stop. This usually builds up over time rather than right away. The good news is this is well known and manageable. Keep taking both as prescribed, and let your care team know so they can watch you more closely.
Effect: Additive increased bleeding risk when sertraline is combined with phenprocoumon (a coumarin anticoagulant).
Mechanism: SSRIs inhibit serotonin reuptake into platelets, depleting platelet serotonin needed for hemostasis; this is pharmacodynamic and additive to phenprocoumon's anticoagulant effect. Neither agent's activation depends on the other.
- Direction: Increased bleeding risk (PD interaction, not primarily PK).
- Onset: Delayed. Evidence: Probable (case-control/cohort data). Severity: Major.
- Management: Monitor for bleeding (epistaxis, ecchymosis, hematoma, petechiae, GI bleeding); reinforce INR monitoring; counsel patient on bleeding signs. Dose may be individualized by the care team.
What happens
An increased risk of bleeding
Interaction Deep Dive
If sertraline is administered together with an anticoagulant, watch the patient for indicators of heightened bleeding and warn them about the elevated bleeding risk.1. Platelet release of serotonin plays a key role in preserving hemostasis. According to case-control and cohort investigations, taking SSRIs (for example, sertraline) alongside anticoagulants has been linked to a greater bleeding risk 231. Using sertraline at the same time as an anticoagulant can heighten the likelihood of bleeding. Reported bleeding episodes have encompassed epistaxis, ecchymosis, hematoma, petechiae, and hemorrhages that are life-threatening 1.
Why it happens (mechanism)
Release of serotonin by platelets; additive effects on hemostasis
How to manage this interaction
This combination can be managed safely with attention from your care team. Typically they will:
- Watch you more closely for signs of bleeding.
- Continue checking your clotting (INR), since phenprocoumon is a blood thinner that needs regular monitoring.
- Adjust and individualize your doses as needed.
What you should do: Keep taking both medicines exactly as prescribed. Do not stop either on your own. Tell your pharmacist or doctor right away if you notice nosebleeds, easy bruising, blood in urine or stool, black stools, pink or red spots on the skin, or bleeding that won't stop.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
4 reports — tap to read
a) A retrospective cohort study (n=234) found a higher risk of clinically relevant bleeding (hospital admission because of bleeding) among patients taking warfarin for atrial fibrillation while also receiving SSRI therapy or within 2 weeks after stopping an SSRI. Patients with a mean age of 72 +/- 7 years taking warfarin plus an SSRI (n=117) were paired with randomly chosen patients who took warfarin alone (n=117). The SSRIs used were FLUoxetine, citalopram, PARoxetine, sertraline, fluvoxaMINE, or escitalopram. In the warfarin plus SSRI group, nine patients had 11 bleeding episodes across 213.9 treatment years, while in the warfarin-only group, 10 patients had 14 bleedings across 586.4 treatment years. The respective total bleeding incidences were 51.4 and 23.9 per 1000 treatment years. Compared with warfarin alone, the hazard ratio for first bleedings during warfarin plus SSRI treatment was 3.49 (95% CI; 1.37 to 8.91, p=0.009). The SSRIs involved in patients who bled during concurrent use were sertraline or citalopram. Adding an SSRI was not linked to a change in warfarin dose or INR (p=0.48 and p=0.31 respectively). The study's findings may be constrained by prior bleeding events, unknown patient adherence, and the exclusion of clopidogrel, dipyridamol, corticosteroids, and anticoagulants other than warfarin from the model 2.
b) A population-based, case-controlled study of patients newly starting coumarins (acenocoumarol and phenprocoumon) together with selective serotonin reuptake inhibitors (SSRIs) produced an elevated risk of hospitalization from non-gastrointestinal bleeding. Drawing on national pharmacy and hospitalization records in the Netherlands, investigators identified 1848 cases admitted for abnormal bleeding and compared them with 5818 control subjects who were also using a coumarin. The median treatment duration in patients was 220 days (range, 1 to 4690 days). Patients receiving SSRIs had a greater risk of hospitalization for non-gastrointestinal bleeding (adjusted odds ratio (OR) 1.7, 95% confidence interval (CI), 1.1 to 2.5); however, the rate of gastrointestinal bleeding (adjusted OR 0.8, 95% CI, 0.4 to 1.5) was not significantly different 3.
c) In a non-blinded, randomized, placebo-controlled trial with 12 healthy volunteers, the impact of sertraline on the plasma protein binding of warfarin was evaluated. On days and 32 of the study, all participants were given warfarin 0.75 mg/kg. Starting on day 11, each volunteer was randomized to either the sertraline or placebo group; the sertraline was raised progressively from 50 mg/day to 200 mg/day. Prothrombin time was measured before each warfarin dose and at intervals thereafter. The investigators concluded that sertraline did not enhance the anticoagulant effects of warfarin to a clinically significant extent, even though sertraline was administered at a higher-than-usual dose 4.
d) Case reports and epidemiological studies (case-control and cohort studies) have shown a link between the use of drugs that interfere with serotonin reuptake and the occurrence of gastrointestinal bleeding. Based on data from published observational studies, exposure to SSRIs, especially in the month prior to delivery, has been associated with a less than 2-fold increase in the risk of postpartum hemorrhage. Bleeding events associated with SSRIs and SNRIs have ranged from ecchymosis, hematoma, epistaxis, and petechiae to life-threatening hemorrhages 1.
Common questions
Can I take Sertraline and Phenprocoumon together?
Taking sertraline with phenprocoumon raises your bleeding risk, so keep taking both as prescribed but watch for bleeding signs and let your care team monitor you closely. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Sertraline and Phenprocoumon interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How is the Sertraline and Phenprocoumon interaction managed?
This combination can be managed safely with attention from your care team. Typically they will: Watch you more closely for signs of bleeding. Continue checking your clotting (INR), since phenprocoumon is a blood thinner that needs regular monitoring. Adjust and individualize your doses as needed. What you should do: Keep taking both medicines exactly as prescribed. Do not stop either on your own.… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Sertraline or Phenprocoumon need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- Product Information: ZOLOFT oral tablets, oral solution, sertraline hydrochloride oral tablets, oral solution. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. DailyMed
- Wallerstedt SM, Gleerup H, Sundstrom A, et al: Risk of clinically relevant bleeding in warfarin-treated patients-influence of SSRI treatment. Pharmacoepidemiol Drug Saf 2009; 18(5):412-416. DOI
- Schalekamp T, Klungel OH, Souverein PC, et al: Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 2008; 168(2):180-185. PubMed
- Apseloff G, Wilner K, Gerber N, et al: Effect of sertraline on protien binding of warfarin. Clin Pharmacokinet 1997; 32 (suppl. 1):37-42.
Keep reading about Sertraline
Keep reading about Phenprocoumon
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist